ACR 2022 Tweet by Md Yuzaiful Md Yusof
Tweet
Related Content
MAS, the most severe complication of Still’s disease, is increasingly recognized as a cytokine-driven hyperinflammatory state centered on interferon gamma (IFNγ). Therapeutic advances presented at EULAR 2026 demonstrate both consolidation of established pathways and expansion into novel biologic strategies.
Still's Disease and Fever
Jack Cush, MD
May 6, 2026
Dr. Jack Cush reviews Still's disease and fevers.
APR: Still's Disease & Fever
May 5, 2026


